文献速递关节外科创伤骨科

血清D-二聚体检测对假体周围关节感染的诊断及再植入时机判断具有前景

Serum D-Dimer Test Is Promising for the Diagnosis of Periprosthetic Joint Infection and Timing of Reimplantation.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

该前瞻性研究纳入245例接受初次或翻修关节置换术的患者,比较血清D-二聚体、红细胞沉降率(ESR)和C反应蛋白(CRP)对假体周围关节感染(PJI)的诊断价值。结果显示PJI患者D-二聚体中位数显著高于无菌性失败患者,以850 ng/mL为阈值时D-二聚体敏感度89%、特异度93%,优于ESR和CRP。作者认为D-二聚体是诊断PJI有前景的标志物,并可能有助于确定再植入的最佳时机。

要点

  • PJI患者血清D-二聚体中位数为1110 ng/mL,显著高于无菌性失败患者的299 ng/mL(p<0.0001)。
  • 以850 ng/mL为最佳阈值时,D-二聚体诊断PJI的敏感度为89%、特异度为93%。
  • D-二聚体诊断性能优于ESR(敏感度73%、特异度78%)和CRP(敏感度79%、特异度80%)。

核心结论

  • 血清D-二聚体似乎是诊断PJI有前景的标志物,并可能对确定再植入的最佳时机有较大实用价值。

研究设计与样本

  • 前瞻性研究,旨在纳入接受初次和翻修关节置换术的患者。
  • 队列共245例,包括初次关节置换23例、无菌性失败翻修86例、PJI翻修57例、再植入29例、其他部位感染50例。
  • PJI采用肌肉骨骼感染学会(Musculoskeletal Infection Society)标准定义。
  • 所有患者术前测量血清D-二聚体、红细胞沉降率(ESR)和C反应蛋白(CRP)水平。

主要发现

  • PJI患者D-二聚体中位数为1110 ng/mL(范围243至8487 ng/mL),无菌性失败患者为299 ng/mL(范围106至2571 ng/mL),PJI组显著更高(p<0.0001)。
  • 使用Youden指数确定850 ng/mL为血清D-二聚体诊断PJI的最佳阈值。
  • D-二聚体诊断PJI的敏感度为89%、特异度为93%,优于ESR和CRP。
  • ESR诊断PJI的敏感度为73%、特异度为78%;CRP诊断PJI的敏感度为79%、特异度为80%。
  • ESR与CRP联合诊断PJI的敏感度为84%(95%CI 76%至90%)、特异度为47%(95%CI 36%至58%)。

关键数值与推荐

  • PJI定义采用肌肉骨骼感染学会标准。
  • 血清D-二聚体诊断PJI的最佳阈值为850 ng/mL(基于Youden指数)。
  • D-二聚体诊断PJI:敏感度89%、特异度93%。
  • ESR诊断PJI:敏感度73%、特异度78%;CRP诊断PJI:敏感度79%、特异度80%。
  • ESR联合CRP诊断PJI:敏感度84%(95%CI 76%至90%)、特异度47%(95%CI 36%至58%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the availability of a battery of tests, the diagnosis of periprosthetic joint infection (PJI) continues to be challenging. Serum D-dimer assessment is a widely available test that detects fibrinolytic activities that occur during infection. We hypothesized that patients with PJI may have a high level of circulating D-dimer and that the presence of a high level of serum D-dimer may be a sign of persistent infection in patients awaiting reimplantation. METHODS: This prospective study was initiated to enroll patients undergoing primary and revision arthroplasty. Our cohort consisted of 245 patients undergoing primary arthroplasty (n = 23), revision for aseptic failure (n = 86), revision for PJI (n = 57), or reimplantation (n = 29) or who had infection in a site other than a joint (n = 50). PJI was defined using the Musculoskeletal Infection Society criteria. In all patients, serum D-dimer level, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) level were measured preoperatively. RESULTS: The median D-dimer level was significantly higher (p < 0.0001) for the patients with PJI (1,110 ng/mL [range, 243 to 8,487 ng/mL]) than for the patients with aseptic failure (299 ng/mL [range, 106 to 2,571 ng/mL). Using the Youden index, 850 ng/mL was determined as the optimal threshold value for serum D-dimer for the diagnosis of PJI. Serum D-dimer outperformed both ESR and serum CRP, with a sensitivity of 89% and a specificity of 93%. ESR and CRP had a sensitivity of 73% and 79% and a specificity of 78% and 80%, respectively. The sensitivity and specificity of ESR and CRP combined was 84% (95% confidence interval [CI], 76% to 90%) and 47% (95% CI, 36% to 58%), respectively. CONCLUSIONS: It appears that serum D-dimer is a promising marker for the diagnosis of PJI. This test may also have a great utility for determining the optimal timing of reimplantation. LEVEL OF EVIDENCE: Diagnostic Level II. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Shahi A, Kheir MM, Tarabichi M, et al. Serum D-Dimer Test Is Promising for the Diagnosis of Periprosthetic Joint Infection and Timing of Reimplantation. J Bone Joint Surg Am. 2017. PMID: 28872523. doi:10.2106/JBJS.16.01395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。